These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26625652)

  • 21. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year follow up of term and near-term infants treated with inhaled nitric oxide.
    Ichiba H; Matsunami S; Itoh F; Ueda T; Ohsasa Y; Yamano T
    Pediatr Int; 2003 Jun; 45(3):290-3. PubMed ID: 12828583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide and intravenous magnesium sulphate for the treatment of persistent pulmonary hypertension of the newborn.
    Boo NY; Rohana J; Yong SC; Bilkis AZ; Yong-Junina F
    Singapore Med J; 2010 Feb; 51(2):144-50. PubMed ID: 20358154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methemoglobin to cumulative nitric oxide ratio and response to inhaled nitric oxide in PPHN.
    Pabalan MJ; Nayak SP; Ryan RM; Kumar VH; Lakshminrusimha S
    J Perinatol; 2009 Oct; 29(10):698-701. PubMed ID: 19554014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use.
    Konduri GG; Menzin J; Frean M; Lee T; Potenziano J; Singer J
    J Med Econ; 2015; 18(8):612-8. PubMed ID: 25853867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial.
    Sadiq HF; Mantych G; Benawra RS; Devaskar UP; Hocker JR
    J Perinatol; 2003 Mar; 23(2):98-103. PubMed ID: 12673257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of inhaled nitric oxide in preterm neonates - a five-year experience in a tertiary neonatal centre.
    Gaddam Bhoomaiah S; Rasiah SV
    Acta Paediatr; 2015 Sep; 104(9):880-2. PubMed ID: 26032757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of inhaled nitric oxide treatment in premature infants with acute pulmonary hypertension.
    Rallis D; Deierl A; Atreja G; Chaban B; Banerjee J
    Early Hum Dev; 2018 Dec; 127():1-5. PubMed ID: 30205295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical application of inhaled nitric oxide in hypoxic respiratory failure of preterm infants].
    Li JH; Wu JL; Mu DZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1100-3. PubMed ID: 24342207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhaled nitric oxide therapy in preterm infants].
    Hoehn T; Krause MF; Bührer C
    Klin Padiatr; 2000; 212(2):47-52. PubMed ID: 10812552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled Pulmonary Vasodilators: Are There Indications Within the Pediatric ICU?
    Kuch BA; Saville AL; Sanchez De Toledo J; Venkataraman ST
    Respir Care; 2017 Jun; 62(6):678-698. PubMed ID: 28546372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Persistent pulmonary hypertension in premature and newborn infants: selective pulmonary vasodilation with inhaled nitric oxide (iNO)].
    Herkenhoff M; Schaible T; Reiss I; Kandzora J; Möller J; Gortner L
    Z Geburtshilfe Neonatol; 1998; 202(1):25-9. PubMed ID: 9577919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early functional echocardiogram and inhaled nitric oxide: usefulness in managing neonates born following extreme preterm premature rupture of membranes (PPROM).
    Shah DM; Kluckow M
    J Paediatr Child Health; 2011 Jun; 47(6):340-5. PubMed ID: 21309877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of Preterm Neonates with a Birth Weight <1,500 g with Severe Hypoxemic Respiratory Failure Rescued by Inhaled Nitric Oxide Therapy and High-Frequency Oscillatory Ventilation.
    Golfar A; Bhogal J; Kamstra B; Hudson-Mason A; Qureshi M; Schmölzer GM; Cheung PY
    Neonatology; 2017; 112(3):274-280. PubMed ID: 28704817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide for the treatment of preterm infants with severe RDS and pulmonary hypertension.
    Dani C; Corsini I; Cangemi J; Vangi V; Pratesi S
    Pediatr Pulmonol; 2017 Nov; 52(11):1461-1468. PubMed ID: 29058384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS).
    J Pediatr; 2000 May; 136(5):611-7. PubMed ID: 10802492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled nitric oxide in neonates with persistent pulmonary hypertension.
    Tworetzky W; Bristow J; Moore P; Brook MM; Segal MR; Brasch RC; Hawgood S; Fineman JR
    Lancet; 2001 Jan; 357(9250):118-20. PubMed ID: 11197402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric therapy in preterm infants: rationalised approach based on functional neonatal echocardiography.
    Cheng DR; Peart S; Tan K; Sehgal A
    Acta Paediatr; 2016 Feb; 105(2):165-71. PubMed ID: 26450016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use.
    Todd Tzanetos DR; Housley JJ; Barr FE; May WL; Landers CD
    Respir Care; 2015 May; 60(5):644-50. PubMed ID: 25650437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled nitric oxide in the treatment of preterm infants.
    Miller SS; Rhine WD
    Early Hum Dev; 2008 Nov; 84(11):703-7. PubMed ID: 18930359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.